Filtered By:
Management: WHO
This page shows you your search results in order of date. This is page number 9.
Order by Relevance | Date
Total 8714 results found since Jan 2013.
The impact of COVID-19 pandemic on elderly with neurocognitive disorders
In conclusion, the combined effect of neurocognitive disorders and the pandemic exceeds the healthcare system's demands, posing in some cases insurmountable challenges. To minimize the negative effect of future similar conditions, focus should be given on the following directions: Patient-oriented, holistic protocols for systematic monitoring of clinical course, future cognitive decline, and timely psychiatric/neuropsychological interventions when necessary. Specialized training for caregivers' and nursing staff focusing on the inclusion of self-hygiene measures in patients' daily routine. Patients' familiarization with on...
Source: Psychiatriki - July 14, 2023 Category: Psychiatry Authors: Maria Basta Eleni Skourti Source Type: research
COVID-19 lessons to protect populations against future pandemics by implementing PPPM principles in healthcare
AbstractThe coronavirus disease 2019 (COVID-19) pandemic has continued for more than 3 years, placing a huge burden on society worldwide. Although the World Health Organization (WHO) has declared an end to COVID-19 as a Public Health Emergency of International Concern (PHEIC), it is still considered a global threat. Previously, there has been a long debate as to whether the COVID-19 emergency will eventually end or transform into a more common infectious disease from a PHEIC, and how should countries respond to similar pandemics in the future more time-efficiently and cost-effectively. We reviewed the past, middle and cu...
Source: EPMA Journal - July 14, 2023 Category: International Medicine & Public Health Source Type: research
Vaccination against coronavirus disease 2019 in patients with pulmonary hypertension: a national prospective cohort study
CONCLUSIONS: COVID-19 vaccination did not significantly augment the PH-related major adverse events for patients with WHO groups 1 and 4 PH, although there were some tolerable side effects. A large-scale randomized controlled trial is warranted to confirm this finding. The final approval of the COVID-19 vaccination for patients with PH as a public health strategy is promising.PMID:37439342 | DOI:10.1097/CM9.0000000000002767
Source: Chinese Medical Journal - July 13, 2023 Category: General Medicine Authors: Xiaohan Wu Jingyi Li Jieling Ma Qianqian Liu Lan Wang Yongjian Zhu Yue Cui Anyi Wang Cenjin Wen Luhong Qiu Yinjian Yang Dan Lu Xiqi Xu Xijie Zhu Chunyan Cheng Duolao Wang Zhicheng Jing Source Type: research
